BioSpace News Archive

Press Releases

Assertio Reports Second Quarter 2024 Financial Results

August 8, 2024
·
24 min read
Press Releases

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

August 8, 2024
·
5 min read
Press Releases

IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024

August 8, 2024
·
3 min read
Press Releases

Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 8, 2024
·
11 min read
Press Releases

Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of Medicine

August 8, 2024
·
14 min read
Press Releases

CENTOGENE Receives Delisting Notice From Nasdaq

August 8, 2024
·
5 min read
Press Releases

FibroBiologics Files 2024 Second Quarter Report

August 8, 2024
·
1 min read
Press Releases

FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose

August 8, 2024
·
3 min read
Press Releases

Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)

August 8, 2024
·
12 min read
Press Releases

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

August 8, 2024
·
8 min read